Advertisement
Screener

CARDIFF ONCOLOGY, INC. (CRDF) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.0 / 5 stars · 44/111 Roast Me

CARDIFF ONCOLOGY, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

CARDIFF ONCOLOGY, INC. (CRDF) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 11.79 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11

  • CARDIFF ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 10.93M shares, a 19.81% decline year-over-year.
  • CARDIFF ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 13.63M shares, a 22.74% increase year-over-year.
  • CARDIFF ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 11.11M shares, a 3.85% increase year-over-year.
  • CARDIFF ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 10.69M shares, a 5.37% decline year-over-year.
  • CARDIFF ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 10.76M shares, a 3.45% decline from fiscal 2024.
  • CARDIFF ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 11.14M shares, a 17.79% increase from fiscal 2023.
  • CARDIFF ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 9.46M shares, a 0.30% increase from fiscal 2022.
  • CARDIFF ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 9.43M shares, a 13.85% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-3011.79M shares
10-Q · filed 2026-08-11
2026-03-3110.93M shares
10-Q · filed 2026-05-14
2025-12-3110.76M shares
10-K · filed 2026-02-24
2025-09-3012.32M shares
10-Q · filed 2025-11-06
2025-06-3014.49M shares
10-Q · filed 2026-08-11
2025-03-3113.63M shares
10-Q · filed 2026-05-14
2024-12-3111.14M shares
10-K · filed 2026-02-24
2024-09-3011.16M shares
10-Q · filed 2025-11-06
2024-06-3011.16M shares
10-Q · filed 2025-07-29
2024-03-3111.11M shares
10-Q · filed 2025-05-08
2023-12-319.46M shares
10-K · filed 2025-02-27
2023-09-309.46M shares
10-Q · filed 2024-11-07
2023-06-309.41M shares
10-Q · filed 2024-08-08
2023-03-3110.69M shares
10-Q · filed 2024-05-02
2022-12-319.43M shares
10-K · filed 2024-02-29
2022-09-3010.93M shares
10-Q · filed 2023-11-02
2022-06-3010.96M shares
10-Q · filed 2023-08-09
2022-03-3111.30M shares
10-Q · filed 2023-05-04
2021-12-3110.95M shares
10-K · filed 2023-03-02
2021-09-3010.74M shares
10-Q · filed 2022-11-03
2021-06-3010.14M shares
10-Q · filed 2022-08-04
2021-03-319.03M shares
10-Q · filed 2022-05-05
2020-12-319.81M shares
10-K · filed 2022-02-24
2020-09-3012.84M shares
10-Q · filed 2021-11-04
2020-06-3017.81M shares
10-Q · filed 2021-08-05
2020-03-3111.50M shares
10-Q · filed 2021-05-06
2019-12-3111.62M shares
10-K · filed 2021-02-25
2019-09-305.90M shares
10-Q · filed 2020-11-05
2019-06-305.45M shares
10-Q · filed 2020-08-11
2019-03-313.74M shares
10-Q · filed 2020-05-07
2018-12-313.76M shares
10-K · filed 2020-02-27
2018-09-303.82M shares
10-Q · filed 2019-11-07		22.91M shares
10-Q · filed 2018-11-07
2018-06-304.73M shares
10-Q · filed 2019-08-08		28.40M shares
10-Q · filed 2018-08-03
2018-03-31367.22K shares
10-Q · filed 2019-05-07		26.44M shares
10-Q · filed 2018-05-08
2017-12-31408.10K shares
10-K · filed 2019-03-06		29.38M shares
10-K · filed 2018-02-26
2017-09-301.21M shares
10-Q · filed 2018-11-07		14.57M shares
10-Q · filed 2017-11-09
2017-06-30786.12K shares
10-Q · filed 2018-08-03		9.43M shares
10-Q · filed 2017-08-09
2017-03-3111.23M shares
10-Q · filed 2018-05-08
2016-12-3110.40M shares
10-K · filed 2018-02-26
2016-09-3011.05M shares
10-Q · filed 2017-11-09
2016-06-3011.11M shares
10-Q · filed 2017-08-09
2016-03-3112.70M shares
10-Q · filed 2017-05-10
2015-12-3111.58M shares
10-K · filed 2017-03-15
2015-09-3011.14M shares
10-Q · filed 2016-11-09
2015-06-3011.66M shares
10-Q · filed 2016-08-04
2015-03-3111.93M shares
10-Q · filed 2016-05-10
2014-12-3110.23M shares
10-K · filed 2017-03-15
2014-09-309.59M shares
10-Q · filed 2015-11-09		10.60M shares
10-Q · filed 2014-11-06
2014-06-309.25M shares
10-Q · filed 2015-08-10		10.26M shares
10-Q · filed 2014-08-07
2014-03-3110.72M shares
10-Q · filed 2015-05-05
2013-12-3110.58M shares
10-K · filed 2016-03-10
2013-09-3010.26M shares
10-Q · filed 2014-11-06
2013-06-3010.89M shares
10-Q · filed 2013-08-14		10.89M shares
10-Q · filed 2014-08-07
2013-03-3111.05M shares
10-Q · filed 2014-05-12
2012-12-3110.80M shares
10-K · filed 2015-03-12
2012-09-309.12M shares
10-Q · filed 2013-11-14		9.12M shares
10-Q · filed 2012-11-14
2012-06-308.89M shares
10-Q · filed 2013-08-14		8.89M shares
10-Q · filed 2012-08-14		8.89M shares
10-Q · filed 2013-08-14		7.89M shares
10-Q · filed 2012-08-14
2012-03-317.00M shares
10-Q · filed 2013-05-14
2011-12-316.13M shares
10-K · filed 2014-03-17
2011-09-305.26M shares
10-Q · filed 2012-11-14
2011-06-30955.77K shares
10-Q · filed 2012-08-14		3.56M shares
10-Q · filed 2012-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Vaxart, Inc. (VXRT)United States$0.080B3.84
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Advertisement